Search

A set of low-cost monometallic Fe, Ni, and bimetallic Fe–Ni bifunctional H–Y-5.1 catalysts with different metal ratios were synthesized by sequential incipient wetness impregnation. The catalysts were characterized in detail by N2 physisorption, Fourier transform infrared spectroscopy with pyridine, inductively coupled plasma optical emission spectroscopy, X-ray diffraction (XRD), transmission and scanning electron microscopy (TEM–SEM), magic angle spinning nuclear magnetic resonance, X-ray photoelectron spectroscopy (XPS), Mössbauer spectroscopy, magnetic measurements, temperature-programmed reduction (TPR), and X-ray absorption spectroscopy (XAS). The results revealed that introduction of Fe led to a decrease of strong acid sites and an increase of medium Brønsted acid sites, while introduction of Ni increased the number of Lewis acid sites. The particle size of iron was approx. 5 nm, being ca. fourfold higher for nickel. XPS demonstrated higher iron content on the catalyst surface compared to nickel. Both Mössbauer spectroscopy and magnetic measurement confirmed the ferromagnetic behavior of all catalysts. In addition, the results from XRD, TEM, XPS, XAS, and magnetization suggested strong Fe–Ni nanoparticle interactions, which were supported by modeling of TPR profiles. Catalytic results of the co-processing of fossil feedstock with lignin-derived isoeugenol clearly showed that both product distribution and activity of Fe–Ni catalysts strongly depend on the metals' ratio and their interactions. Key properties affected by the Fe–Ni metal ratio, which played a positive role in co-processing, were a smaller medial metal nanoparticle size (<6 nm), a lower metal–acid site ratio, as well as presence in the catalyst of fcc FeNi alloy structure and fcc Ni doped with Fe. [ABSTRACT FROM AUTHOR]

Hydrodeoxygenation (HDO) of isoeugenol (IE) was investigated using bimetallic iridium-rhenium and platinum-rhenium catalysts supported on alumina in the temperature and pressure ranges of 200-250 °C and 17-40 bar in nonpolar dodecane as a solvent. The main parameters were catalyst type, hydrogen pressure, and initial concentration. Nearly quantitative yield of the desired product, propylcyclohexane (PCH), at complete conversion in 240 min was obtained with Ir-Re/Al 2 O 3 prepared by the deposition-precipitation method using 0.1 mol/L IE initial concentration. High iridium dispersion together with a modification effect of rhenium provided in situ formation of the IrRe active component with reproducible catalytic activity for selective HDO of IE to PCH. The reaction rate was shown to increase with the increasing initial IE concentration promoting also HDO and giving a higher liquid phase mass balance. Increasing hydrogen pressure benefits the PCH yield., Competing Interests: The authors declare no competing financial interest.

In this paper, cellular management of fluorescent nanodiamonds (FNDs) has been studied for better understanding in the design for potential applications of FNDs in biomedicine. The FNDs have shown to be photostable probes for bioimaging and thus are well-suited, for example, long-term tracking purposes. The FNDs also exhibit good biocompatibility and, in general, low toxicity for cell labeling. To demonstrate the underlying mechanism of cells coping the low but potentially toxic effects by nondegradable FNDs, we have studied their temporal intracellular trafficking. The FNDs were observed to be localized as distinct populations inside cells in early endosomes, lysosomes, and in proximity to the plasma membrane. The localization of FNDs in early endosomes suggests the internalization of FNDs, and lysosomal localization, in turn, can be interpreted as a prestate for exocytosis via lysosomal degradation pathway. The endocytosis and exocytosis appear to be occurring simultaneously in our observations. The mechanism of continuous endocytosis and exocytosis of FNDs could be necessary for cells to maintain normal proliferation. Furthermore, 120 h cell growth assay was performed to verify the long-term biocompatibility of FNDs for cellular studies., Competing Interests: The authors declare no competing financial interest.

The oral bioavailability of a poorly water-soluble drug is often inadequate for the desired therapeutic effect. The bioavailability can be improved by enhancing the physicochemical properties of the drug (e.g., dissolution rate, permeation across the gastrointestinal tract). Other approach include shielding the drug from the gastric metabolism and targeted drug release to obtain optimal drug absorption. In this study, a poorly water-soluble model drug, griseofulvin, was encapsulated as disordered solid dispersions into Eudragit L 100-55 enteric polymer micromatrix particles, which were produced by electrospraying. Similar micromatrix particles were also produced with griseofulvin-loaded thermally oxidized mesoporous silicon (TOPSi) nanoparticles dispersed to the polymer micromatrices. The in vitro drug dissolution at pH 1.2 and 6.8, and permeation at pH 7.4 across Caco-2/HT29 cell monolayers from the micromatrix particles, were investigated. The micromatrix particles were found to be gastro-resistant, while at pH 6.8 the griseofulvin was released very rapidly in a fast-dissolving form. Compared to free griseofulvin, the permeability of encapsulated griseofulvin across the intestinal cell monolayers was greatly improved, particularly for the TOPSi-doped micromatrix particles. The griseofulvin solid dispersions were stable during storage for 6 months at accelerated conditions. Overall, the method developed here could prove to be a useful oral drug delivery solution for improving the bioavailability of poorly water-soluble or otherwise problematic drugs.